# A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)

> **NCT01507194** · PHASE2 · COMPLETED · sponsor: **Accenture** · enrollment: 131 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** Ondansetron
- **DRUG:** Vestipitant

## Key facts

- **NCT ID:** NCT01507194
- **Lead sponsor:** Accenture
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2012-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01507194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01507194, "A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01507194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*